TGFB1 and recessive dystrophic epidermolysis bullosa: The involvement of the TGF-β pathway in modulating disease variability was elegantly demonstrated in RDEB fibroblasts from monozygotic twins, with canonical (Smads) and non canonical (MAPKs) TGF-pathways more active in the fibroblasts of the more affected twin.